143 related articles for article (PubMed ID: 30041845)
1. Science in Focus: Biological Optimisation of Radiotherapy Fraction Size in an Era of Immune Oncology.
Wilkins A; Melcher A; Somaiah N
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):605-608. PubMed ID: 30041845
[No Abstract] [Full Text] [Related]
2. Optimisation in radiotherapy I: defining the problem.
Ebert MA
Australas Phys Eng Sci Med; 1997 Sep; 20(3):164-76. PubMed ID: 9409017
[TBL] [Abstract][Full Text] [Related]
3. Pre-segmented 2-Step IMRT with subsequent direct machine parameter optimisation - a planning study.
Bratengeier K; Meyer J; Flentje M
Radiat Oncol; 2008 Nov; 3():38. PubMed ID: 18990227
[TBL] [Abstract][Full Text] [Related]
4. Optimisation in radiotherapy. II: Programmed and inversion optimisation algorithms.
Ebert M
Australas Phys Eng Sci Med; 1997 Dec; 20(4):220-30. PubMed ID: 9503694
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Relationship Between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy.
Liu J; Dwyer T; Marriott K; Millar J; Haworth A
IEEE Trans Vis Comput Graph; 2018 Jan; 24(1):319-329. PubMed ID: 28866546
[TBL] [Abstract][Full Text] [Related]
6. Optimisation in radiotherapy. III: Stochastic optimisation algorithms and conclusions.
Ebert M
Australas Phys Eng Sci Med; 1997 Dec; 20(4):231-41. PubMed ID: 9503695
[TBL] [Abstract][Full Text] [Related]
7. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.
Kierkels RG; Korevaar EW; Steenbakkers RJ; Janssen T; van't Veld AA; Langendijk JA; Schilstra C; van der Schaaf A
Radiother Oncol; 2014 Sep; 112(3):430-6. PubMed ID: 25220369
[TBL] [Abstract][Full Text] [Related]
8. Data for TROTS - The Radiotherapy Optimisation Test Set.
Breedveld S; Heijmen B
Data Brief; 2017 Jun; 12():143-149. PubMed ID: 28417100
[TBL] [Abstract][Full Text] [Related]
9. Clinical Development of Novel Drug-Radiotherapy Combinations.
Ahmad SS; Crittenden MR; Tran PT; Kluetz PG; Blumenthal GM; Bulbeck H; Baird RD; Williams KJ; Illidge T; Hahn SM; Lawrence TS; Spears PA; Walker AJ; Sharma RA
Clin Cancer Res; 2019 Mar; 25(5):1455-1461. PubMed ID: 30498095
[TBL] [Abstract][Full Text] [Related]
10. Dose-based optimisation for multi-leaf collimator tracking during radiation therapy.
Mejnertsen L; Hewson E; Nguyen DT; Booth J; Keall P
Phys Med Biol; 2021 Mar; 66(6):065027. PubMed ID: 33607648
[TBL] [Abstract][Full Text] [Related]
11. Abstracts of the 7th Biennial ESTRO Meeting on Physics and Radiation Technology for Clinical Radiotherapy and the pre-meeting workshop on Optimisation of IMRT. Geneva, Switzerland, 13-18 September 2003.
Radiother Oncol; 2003 Sep; 68 Suppl 1():S1-127. PubMed ID: 15641184
[No Abstract] [Full Text] [Related]
12. Radiotherapy as a New Player in Immuno-Oncology.
Wang SJ; Haffty B
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558196
[TBL] [Abstract][Full Text] [Related]
13. Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience.
Pareek N; Cevallos J; Moliner P; Shah M; Tan LL; Chambers V; Baksi AJ; Khattar RS; Sharma R; Rosen SD; Lyon AR
Eur J Heart Fail; 2018 Dec; 20(12):1721-1731. PubMed ID: 30191649
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
[TBL] [Abstract][Full Text] [Related]
15. A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate.
Oldham M; Neal A; Webb S
Radiother Oncol; 1995 Jun; 35(3):248-62. PubMed ID: 7480829
[TBL] [Abstract][Full Text] [Related]
16. Image-guided Adaptive Radiotherapy for Bladder Cancer.
Kong V; Hansen VN; Hafeez S
Clin Oncol (R Coll Radiol); 2021 Jun; 33(6):350-368. PubMed ID: 33972024
[TBL] [Abstract][Full Text] [Related]
17. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
Xu PP; Fu D; Li JY; Hu JD; Wang X; Zhou JF; Yu H; Zhao X; Huang YH; Jiang L; Liu F; Su LP; Chen ZW; Zeng QS; Chen JP; Fang MY; Ma J; Liu T; Song YP; Yu K; Li Y; Qiu LG; Chen XQ; Gu J; Yan JS; Hou M; Huang HY; Wang L; Cheng S; Shen Y; Xiong H; Chen SJ; Zhao WL
Lancet Haematol; 2019 Jun; 6(6):e328-e337. PubMed ID: 31126528
[TBL] [Abstract][Full Text] [Related]
18. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem.
Mu X; Löfroth PO; Karlsson M; Zackrisson B
Radiother Oncol; 2003 Aug; 68(2):181-7. PubMed ID: 12972314
[TBL] [Abstract][Full Text] [Related]
19. Novel Use of Patient-Specific Covariates From Oncology Studies in the Era of Biomedical Data Science: A Review of Latest Methodologies.
Xu R; Chen G; Connor M; Murphy J
J Clin Oncol; 2022 Oct; 40(30):3546-3553. PubMed ID: 35258995
[TBL] [Abstract][Full Text] [Related]
20. Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients.
Lawes R; Carter E; Hussein M; Murray J; McNair HA
Radiography (Lond); 2021 May; 27(2):266-271. PubMed ID: 32830012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
